What is Regional Health Pptys Inc's earnings per share (EPS)?

Regional Health Pptys Inc (RHEPZ) reported diluted earnings per share of $1.09 for fiscal year 2025. This represents a 163.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Regional Health Pptys Inc Financials

RHEPZ

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Regional Health Pptys Inc (RHEPZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RHEPZ FY2025 2026-04-22

FY2025's profit rebound rested more on reported earnings than on cash the core business actually generated.

After FY2023 and FY2024 showed losses that still converted into cash, FY2025 flipped the pattern: net income was $3.4M while operating cash flow was -$2.3M. With interest expense of $2.7M still above operating income of $1.7M, the return to profit did not come from the recurring operating engine alone, so the earnings improvement overstates how self-funding the business became.

FY2025 looks administratively heavy rather than production-heavy: gross margin was 86.9%, but operating margin was only 3.1%. That margin gap suggests the bottleneck is carrying the organization and its financing costs, not generating value above direct costs, so scale only partially translated into durable operating earnings.

Debt has been reduced from $52.2M in FY2022 to $34.7M in FY2025, so absolute borrowing is moving down even though leverage still looks extreme because equity is barely positive. But liquidity remains thin: the current ratio was 0.7x and equity ended at only $349K, which means current obligations still sit on a very small capital cushion and the balance sheet has limited room for working-capital shocks.

Financial Health Signals

Financial health score pending refresh

We are recalculating Regional Health Pptys Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

5/8

Regional Health Pptys Inc passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

-0.67x

For every $1 of reported earnings, Regional Health Pptys Inc generates $-0.67 in operating cash flow (-$2.3M OCF vs $3.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

0.6x

Regional Health Pptys Inc earns $0.6 in operating income for every $1 of interest expense ($1.7M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$53.2M

YoY+189.9%

5Y CAGR+24.8%

10Y CAGR+11.2%

Regional Health Pptys Inc generated $53.2M in revenue in fiscal year 2025. This represents an increase of 189.9% from the prior year.

EBITDA

$3.7M

YoY+67.7%

5Y CAGR-6.4%

Regional Health Pptys Inc's EBITDA was $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.7% from the prior year.

Net Income

$3.4M

YoY+204.7%

Regional Health Pptys Inc reported $3.4M in net income in fiscal year 2025. This represents an increase of 204.7% from the prior year.

EPS (Diluted)

$1.09

YoY+163.0%

Regional Health Pptys Inc earned $1.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 163.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$3.1M

YoY-321.4%

Regional Health Pptys Inc generated -$3.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 321.4% from the prior year.

Cash & Debt

$3.0M

YoY+415.5%

5Y CAGR-6.5%

10Y CAGR+1.0%

Regional Health Pptys Inc held $3.0M in cash against $34.7M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+109.4%

5Y CAGR+18.4%

Regional Health Pptys Inc had 4M shares outstanding in fiscal year 2025. This represents an increase of 109.4% from the prior year.

Margins & Returns

Gross Margin

86.9%

Regional Health Pptys Inc's gross margin was 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

3.1%

YoY+2.3pp

5Y CAGR-9.9pp

10Y CAGR+44.7pp

Regional Health Pptys Inc's operating margin was 3.1% in fiscal year 2025, reflecting core business profitability. This is up 2.3 percentage points from the prior year.

Net Margin

6.3%

YoY+23.9pp

5Y CAGR+10.3pp

10Y CAGR+134.2pp

Regional Health Pptys Inc's net profit margin was 6.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 23.9 percentage points from the prior year.

Return on Equity

965.6%

5Y CAGR+971.8pp

Regional Health Pptys Inc's ROE was 965.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$869K

YoY+64.0%

5Y CAGR+14.1%

10Y CAGR-7.0%

Regional Health Pptys Inc invested $869K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 64.0% from the prior year.

RHEPZ Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$53.2M+189.9%	$18.3M+6.8%	$17.2M-52.2%	$35.9M+34.6%	$26.7M+51.8%	$17.6M
Cost of Revenue	$7.0M	N/A	N/A	N/A	N/A	N/A
Gross Profit	$46.2M	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$12.0M+122.7%	$5.4M-0.1%	$5.4M+16.3%	$4.7M+18.3%	$3.9M+16.5%	$3.4M
Operating Income	$1.7M+933.5%	$161K+119.6%	-$821K+88.0%	-$6.8M-369.3%	$2.5M+10.4%	$2.3M
Interest Expense	$2.7M-1.4%	$2.7M-1.5%	$2.8M+8.8%	$2.5M-5.2%	$2.7M-3.9%	$2.8M
Income Tax	$108K	N/A	N/A	N/A	N/A	N/A
Net Income	$3.4M+204.7%	-$3.2M+17.2%	-$3.9M+43.4%	-$6.9M-481.0%	-$1.2M-71.8%	-$688K
EPS (Diluted)	$1.09+163.0%	$-1.73-108.2%	$21.05+335.7%	$-8.93-52.1%	$-5.87	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$21.2M+1.9%	$20.8M+37.2%	$15.1M+50.5%	$10.1M+39.9%	$7.2M+27.1%	$5.7M+33.9%	$4.2M-2.3%	$4.3M
Cost of Revenue	$4.5M	N/A	$2.5M	N/A	N/A	N/A	N/A	N/A
Gross Profit	$16.7M	N/A	$12.7M	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$6.5M+77.7%	$3.7M-1.2%	$3.7M+52.9%	$2.4M+8.9%	$2.2M+68.6%	$1.3M+8.1%	$1.2M-0.4%	$1.2M
Operating Income	-$702K-122.8%	$3.1M+619.2%	-$594K-16.9%	-$508K-59.7%	-$318K-158.8%	$541K+280.3%	-$300K-240.2%	$214K
Interest Expense	$522K-19.9%	$652K-13.2%	$751K+22.1%	$615K-5.8%	$653K-5.4%	$690K+1.9%	$677K+1.2%	$669K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.2M-145.2%	$2.7M-20.2%	$3.4M+333.4%	-$1.4M-14.8%	-$1.3M-122.2%	-$568K+42.2%	-$982K-39.1%	-$706K
EPS (Diluted)	$-0.29	N/A	$1.17+272.1%	$-0.68+27.7%	$-0.94	N/A	$-0.52-36.8%	$-0.38

RHEPZ Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$67.8M+12.1%	$60.5M-2.8%	$62.2M-9.3%	$68.6M-35.1%	$105.7M-2.2%	$108.0M
Current Assets	$16.3M+138.8%	$6.8M	N/A	N/A	N/A	N/A
Cash & Equivalents	$3.0M+415.5%	$582K-41.8%	$1.0M+25.0%	$800K-88.2%	$6.8M+61.9%	$4.2M
Inventory	$1.4M	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$8.0M+138.7%	$3.4M+140.1%	$1.4M-77.7%	$6.3M+193.2%	$2.1M+2.1%	$2.1M
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M
Total Liabilities	$62.8M-1.0%	$63.4M+2.2%	$62.0M-4.4%	$64.9M-31.9%	$95.3M-1.7%	$96.9M
Current Liabilities	$24.2M+18.4%	$20.4M	N/A	N/A	N/A	N/A
Long-Term Debt	$34.7M-11.6%	$39.3M-22.6%	$50.7M-2.8%	$52.2M-1.3%	$52.9M-2.9%	$54.4M
Total Equity	$349K+112.0%	-$2.9M-1677.8%	$185K-95.0%	$3.7M-64.3%	$10.4M-6.4%	$11.1M
Retained Earnings	-$81.8M+3.9%	-$85.1M-3.9%	-$81.9M+32.5%	-$121.4M-6.0%	-$114.5M-1.0%	-$113.4M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$67.3M-0.8%	$67.8M-6.0%	$72.2M+20.0%	$60.1M+1.4%	$59.3M-2.0%	$60.5M+0.7%	$60.1M-2.1%	$61.3M
Current Assets	$16.2M-0.4%	$16.3M	N/A	N/A	N/A	$6.8M	N/A	N/A
Cash & Equivalents	$1.1M-63.3%	$3.0M+200.0%	$1.0M+150.0%	$400K-20.0%	$500K-14.1%	$582K+16.4%	$500K-28.6%	$700K
Inventory	$1.6M+20.0%	$1.4M-5.6%	$1.4M	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$10.1M+25.3%	$8.0M+4.0%	$7.7M+76.7%	$4.4M+20.0%	$3.6M+8.3%	$3.4M+65.3%	$2.0M+11.9%	$1.8M
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M
Total Liabilities	$63.6M+1.3%	$62.8M-9.0%	$69.0M+5.2%	$65.6M+3.4%	$63.4M+0.1%	$63.4M+1.5%	$62.4M-0.5%	$62.7M
Current Liabilities	$25.3M+4.6%	$24.2M	N/A	N/A	N/A	$20.4M	N/A	N/A
Long-Term Debt	$34.5M-0.6%	$34.7M-28.5%	$48.6M-0.7%	$48.9M-0.5%	$49.2M+25.1%	$39.3M-20.9%	$49.7M-1.2%	$50.2M
Total Equity	-$962K-375.6%	$349K+122.7%	-$1.5M+71.8%	-$5.5M-31.1%	-$4.2M-42.5%	-$2.9M-22.6%	-$2.4M-68.0%	-$1.4M
Retained Earnings	-$82.9M-1.4%	-$81.8M+3.5%	-$84.8M+4.1%	-$88.4M-1.7%	-$87.0M-2.2%	-$85.1M-0.7%	-$84.6M-1.2%	-$83.6M

RHEPZ Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$2.3M-216.3%	$1.9M-47.7%	$3.7M+203.2%	-$3.6M-173.5%	$4.9M+277.9%	$1.3M
Capital Expenditures	$869K+64.0%	$530K-44.7%	$958K+240.9%	$281K+128.5%	$123K-72.7%	$450K
Free Cash Flow	-$3.1M-321.4%	$1.4M-48.7%	$2.8M+171.0%	-$3.9M-181.3%	$4.8M+464.6%	$845K
Investing Cash Flow	$15.1M+2949.4%	-$530K+44.7%	-$958K-240.9%	-$281K-128.5%	-$123K+72.7%	-$450K
Financing Cash Flow	-$10.3M-382.4%	-$2.1M+14.3%	-$2.5M-20.2%	-$2.1M+14.6%	-$2.4M-73.6%	-$1.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	$46K+557.1%	$7K	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$890K+29.7%	-$1.3M+29.6%	-$1.8M-416.2%	$569K+141.1%	$236K-75.2%	$953K+950.9%	-$112K-122.2%	$505K
Capital Expenditures	$364K+61.1%	$226K-20.1%	$283K-4.1%	$295K+353.8%	$65K-35.0%	$100K+185.7%	$35K-89.7%	$340K
Free Cash Flow	-$1.3M+16.0%	-$1.5M+28.3%	-$2.1M-859.9%	$274K+60.2%	$171K-80.0%	$853K+680.3%	-$147K-189.1%	$165K
Investing Cash Flow	-$364K-103.7%	$9.8M+71.6%	$5.7M+2029.5%	-$295K-353.8%	-$65K+35.0%	-$100K-185.7%	-$35K+89.7%	-$340K
Financing Cash Flow	-$735K+88.6%	-$6.4M-106.8%	-$3.1M-2470.2%	-$121K+79.4%	-$587K+33.5%	-$883K-1277.3%	$75K+113.3%	-$566K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RHEPZ Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	86.9%	N/A	N/A	N/A	N/A	N/A
Operating Margin	3.1%+2.3pp	0.9%+5.7pp	-4.8%+14.2pp	-19.0%-28.5pp	9.5%-3.6pp	13.1%
Net Margin	6.3%+23.9pp	-17.5%+5.1pp	-22.7%-3.5pp	-19.1%-14.7pp	-4.4%-0.5pp	-3.9%
Return on Equity	965.6%	N/A	-2101.6%-1916.8pp	-184.8%-173.4pp	-11.4%-5.2pp	-6.2%
Return on Assets	5.0%+10.3pp	-5.3%+0.9pp	-6.3%+3.8pp	-10.0%-8.9pp	-1.1%-0.5pp	-0.6%
Current Ratio	0.67+0.3	0.33	N/A	N/A	N/A	N/A
Debt-to-Equity	99.54+113.0	-13.46-287.7	274.24+260.2	14.04+9.0	5.09+0.2	4.90
FCF Margin	-5.9%-13.6pp	7.7%-8.3pp	16.1%+26.8pp	-10.8%-28.7pp	17.9%+13.1pp	4.8%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	78.8%	N/A	83.7%	N/A	N/A	N/A	N/A	N/A
Operating Margin	-3.3%-18.2pp	14.8%+18.8pp	-3.9%+1.1pp	-5.1%-0.6pp	-4.4%-14.0pp	9.6%+16.7pp	-7.1%-12.0pp	5.0%
Net Margin	-5.8%-18.8pp	13.0%-9.3pp	22.3%+36.8pp	-14.4%+3.1pp	-17.5%-7.5pp	-10.0%+13.2pp	-23.2%-6.9pp	-16.3%
Return on Equity	N/A	773.4%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-1.8%-5.8pp	4.0%-0.7pp	4.7%+7.1pp	-2.4%-0.3pp	-2.1%-1.2pp	-0.9%+0.7pp	-1.6%-0.5pp	-1.1%
Current Ratio	0.64-0.0	0.67	N/A	N/A	N/A	0.33	N/A	N/A
Debt-to-Equity	-35.91-135.4	99.54+131.1	-31.59-22.6	-8.97+2.9	-11.82+1.6	-13.46+7.4	-20.86+14.6	-35.46
FCF Margin	-5.9%+1.3pp	-7.2%+6.6pp	-13.8%-16.5pp	2.7%+0.3pp	2.4%-12.7pp	15.1%+18.6pp	-3.5%-7.3pp	3.8%

Note: The current ratio is below 1.0 (0.67), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Regional Health Pptys Inc's annual revenue?

Regional Health Pptys Inc (RHEPZ) reported $53.2M in total revenue for fiscal year 2025. This represents a 189.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Regional Health Pptys Inc's revenue growing?

Regional Health Pptys Inc (RHEPZ) revenue grew by 189.9% year-over-year, from $18.3M to $53.2M in fiscal year 2025.

Is Regional Health Pptys Inc profitable?

Yes, Regional Health Pptys Inc (RHEPZ) reported a net income of $3.4M in fiscal year 2025, with a net profit margin of 6.3%.

What is Regional Health Pptys Inc's EBITDA?

Regional Health Pptys Inc (RHEPZ) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Regional Health Pptys Inc have?

As of fiscal year 2025, Regional Health Pptys Inc (RHEPZ) had $3.0M in cash and equivalents against $34.7M in long-term debt.

What is Regional Health Pptys Inc's gross margin?

Regional Health Pptys Inc (RHEPZ) had a gross margin of 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Regional Health Pptys Inc's operating margin?

Regional Health Pptys Inc (RHEPZ) had an operating margin of 3.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Regional Health Pptys Inc's net profit margin?

Regional Health Pptys Inc (RHEPZ) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Regional Health Pptys Inc's return on equity (ROE)?

Regional Health Pptys Inc (RHEPZ) has a return on equity of 965.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Regional Health Pptys Inc's free cash flow?

Regional Health Pptys Inc (RHEPZ) generated -$3.1M in free cash flow during fiscal year 2025. This represents a -321.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Regional Health Pptys Inc's operating cash flow?

Regional Health Pptys Inc (RHEPZ) generated -$2.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Regional Health Pptys Inc's total assets?

Regional Health Pptys Inc (RHEPZ) had $67.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Regional Health Pptys Inc's capital expenditures?

Regional Health Pptys Inc (RHEPZ) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Regional Health Pptys Inc have outstanding?

Regional Health Pptys Inc (RHEPZ) had 4M shares outstanding as of fiscal year 2025.

What is Regional Health Pptys Inc's current ratio?

Regional Health Pptys Inc (RHEPZ) had a current ratio of 0.67 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Regional Health Pptys Inc's debt-to-equity ratio?

Regional Health Pptys Inc (RHEPZ) had a debt-to-equity ratio of 99.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Regional Health Pptys Inc's return on assets (ROA)?

Regional Health Pptys Inc (RHEPZ) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Regional Health Pptys Inc's cash runway?

Based on fiscal year 2025 data, Regional Health Pptys Inc (RHEPZ) had $3.0M in cash against an annual operating cash burn of $2.3M. This gives an estimated cash runway of approximately 16 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Regional Health Pptys Inc's Piotroski F-Score?

Regional Health Pptys Inc (RHEPZ) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Regional Health Pptys Inc's earnings high quality?

Regional Health Pptys Inc (RHEPZ) has an earnings quality ratio of -0.67x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Regional Health Pptys Inc cover its interest payments?

Regional Health Pptys Inc (RHEPZ) has an interest coverage ratio of 0.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.